Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on May 14, 2025
STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
May 14, 2025
HORSHAM, Pa., May 14, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic …
Codexis Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 14, 2025
Secured first revenue-generating contract for ECO Synthesis™ manufacturing services Company reiterates full-year financial guidance Six presentations to feature the ECO Synthesis platform at upcoming TIDES USA annual meeting, including three from leading …
Korro to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 14, 2025
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor conferences: 2025 RBC Capital Markets Global Healthcare Conference Ram …
Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th
GlobeNewswire
·
May 14, 2025
MENLO PARK, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …
Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine
GlobeNewswire
·
May 14, 2025
Challenge Study measured safety, efficacy against infection and symptomatic disease as well as viral shedding Machine learning analyses identified statistically significant correlates of protection and will be incorporated into the development of Vaxart’s …
BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 14, 2025
MELVILLE, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results …
Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia
GlobeNewswire
·
May 14, 2025
REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that preliminary clinical data from the Phase I COVALENT-103 trial of BMF-500 in …
Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
GlobeNewswire
·
May 14, 2025
BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
May 14, 2025
Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late March 2025 Phase 3 Clinical Trial Results …
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 14, 2025
PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on May 9, 2025, the compensation committee …
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
GlobeNewswire
·
May 14, 2025
MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease; Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in Q3 2025 Strong Balance Sheet with $294.4 Million in Cash and Cash …
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress
GlobeNewswire
·
May 14, 2025
SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. “The first quarter of 2025 represents the first full quarter of execution after shifting strategy …
Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 14, 2025
On track to report topline results from Phase 2 BESTOW trial in kidney transplantation in fourth quarter of 2025 Tegoprubart used as a key component of immunosuppression regimen in its second transplant of a genetically modified pig kidney into a human …
Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment is ongoing in the PIK3CA mutant cohort of the VIKTORIA-1 …
Monogram Technologies Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 14, 2025
Receives FDA Clearance for the mBôs™ TKA System Groundbreaking Trial Set to Deliver one of the World’s First Autonomous Saw-Based Robotic TKA Surgeries on Live Patients Management to Host Business Update Conference Call Today at 4:30 p.m. Eastern Time …
Physician Reveals Concerning Trend in Health Care Pricing and What Can Be Done About It
EIN Presswire
·
May 14, 2025
TX, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- Surveys show most doctors are increasingly concerned about a trend in health care pricing; patients being charged more for the same service, depending on where they go. And most don’t even know it’s …
Dentures Market New Investments, In-Depth Survey, Key Player and Forecast 2024-2033
EIN Presswire
·
May 14, 2025
The primary driver of the dentures market's expansion is growing awareness of oral health. VANCOUVER, BRITISH COLUMBIA, CANADA, May 14, 2025 /EINPresswire.com/ -- The Dentures Market is expected to grow from an estimated USD 2.5 billion in 2024 to USD …
Fluoroscopy Market Set for Growth Driven by Rising Chronic Diseases, Aging Population, and Demand
EIN Presswire
·
May 14, 2025
Increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and advancements in fluoroscopy technologies. VANCOUVER, BRITISH COLUMBIA, CANADA, May 14, 2025 /EINPresswire.com/ -- The Fluoroscopy Market is expected to grow …
Oral Appliances Market Size In 2024 - 2033 : Trends, Top Companies
EIN Presswire
·
May 14, 2025
The Oral Appliances market is expected to grow from an estimated USD 310.1 billion in 2024 to USD 510.7 billion in 2033, at a CAGR of 5.70%. VANCOUVER, BC, CANADA, May 14, 2025 /EINPresswire.com/ -- The Oral Appliances market is expected to grow from …
Lyme Disease Testing Market Growth Research Report 2024-2033 | 250 Pages
EIN Presswire
·
May 14, 2025
The global Lyme Disease Testing market size is expected to grow from USD 11.5 bn by the end of 2024 to USD 24.6 bn by 2033, registering a revenue CAGR of 8.80% VANCOUVER, BC, CANADA, May 14, 2025 /EINPresswire.com/ -- The global Lyme Disease Testing …